Cargando…
小剂量地西他滨治疗较低危骨髓增生异常综合征患者疗效初步观察
OBJECTIVE: To assess the efficiency and safety of low-dose decitabine in patients with lower-risk myelodysplastic syndrome (MDS) to couple with the clinical significance of MDS-related gene mutations. METHODS: This study was done in 4 institutions in Zhejiang Province. A total of 62 newly diagnosed...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342717/ https://www.ncbi.nlm.nih.gov/pubmed/28468092 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.04.009 |
Ejemplares similares
-
地西他滨治疗骨髓增生异常综合征及相关肿瘤的疗效预测因素研究
Publicado: (2017) -
地西他滨桥接异基因造血干细胞移植治疗骨髓增生异常综合征的疗效分析
Publicado: (2015) -
地西他滨联合半量CAG方案治疗骨髓增生异常综合征伴原始细胞增多和急性髓系白血病伴骨髓增生异常相关改变
Publicado: (2018) -
地西他滨10天方案治疗初治老年急性髓系白血病的疗效及安全性初步探讨
Publicado: (2016) -
含地西他滨预处理方案异基因造血干细胞移植治疗骨髓增生异常综合征/慢性粒-单核细胞白血病的疗效及安全性
Publicado: (2019)